| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.5M | +602.4% |
| Cost of Revenue | $17.6M | +1237.1% |
| Gross Profit | $4.9M | +160.6% |
| R&D Expense | $5.2M | +31.1% |
| SG&A Expense | $32.8M | +49.1% |
| Operating Income | -$42.8M | -15.8% |
| Interest Expense | $300K | +0.0% |
| Pre-tax Income | -$53.0M | -49.1% |
| Income Tax | -$10K | -162.5% |
| Net Income | -$68.8M | -93.1% |
| EPS (Basic) | -$4.24 | +97.4% |
| EPS (Diluted) | -$4.24 | +97.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.7M | +306.7% |
| Accounts Receivable | $12.1M | +1612.9% |
| Inventory | $15.4M | +595.6% |
| Current Assets | $51.8M | +503.9% |
| Total Assets | $81.2M | +234.5% |
| Current Liabilities | $47.6M | +173.3% |
| Long-term Debt | $450K | +592.3% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.6M | -64.1% |
| Capital Expenditures | $215K | +216.2% |
| Investing Cash Flow | -$18.8M | -757.6% |
| Financing Cash Flow | $68.2M | +189.5% |
| Free Cash Flow | -$36.8M | -64.6% |
| $50.8M |
| +186.7% |
| Stockholders' Equity | $17.7M | +169.8% |